- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00642265
The Treatment of Clavicular Fractures
January 3, 2023 updated by: University Hospital, Ghent
The Treatment of Displaced, Midshaft Clavicular Fractures: Operative vs Conservative. A Prospected, Randomized Study
Patients with a displaced, shortened, midshaft clavicular fracture are randomized in two groups: conservative or operative treatment. The conservative arm is treated with a sling for 6 weeks. The operative arm is treated with osteosynthesis, within 2 weeks.
Patients are clinically and radiologically evaluated during 1 year. A economical analysis is also done.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aalst, Belgium, 9300
- Stedelijk Ziekenhuis Aalst
-
Brugge, Belgium, 8000
- AZ Sint Jan-Brugge
-
Ghent, Belgium, 9000
- University Hospital Ghent
-
Ghent, Belgium, 9000
- Jan Palfijnziekenhuis
-
Roeselare, Belgium, 8800
- Stedelijk Ziekenhuis Roeselare
-
Tielt, Belgium, 8700
- Sint-Andries Ziekenhuis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 to 65 year
- 100% displaced midshaft clavicular fracture
shortening
- male: 18mm
- female: 14mm
Exclusion Criteria:
- pregnancy
- pathological fracture
- open fracture
- history of frozen shoulder
- ipsilateral fracture of shoulder or scapula
- neurovascular injury
- contraindication to anaesthesia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
operative treatment
|
operative treatment
|
|
Active Comparator: 2
conservative treatment
|
conservative treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Union
Time Frame: 1 year
|
1 year
|
|
Functionality
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cost
Time Frame: 1 year
|
1 year
|
|
Complications
Time Frame: 1 year
|
1 year
|
|
Time to heal
Time Frame: 1 year
|
1 year
|
|
Relation with medication
Time Frame: 1 year
|
1 year
|
|
Relation with smoking
Time Frame: 1 year
|
1 year
|
|
Relation with job
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lieven De Wilde, MD, PhD, University Hospital, Ghent
- Principal Investigator: Bart Berghs, MD, AZ Sint-Jan AV
- Principal Investigator: Pieter-Jan Vandekerckhove, MD, Sint-Andriesziekenhuis Tielt
- Principal Investigator: J. Van Den Daele, MD, Stedelijk Ziekenhuis Roeselare
- Principal Investigator: J. Vanonverschelde, MD, Stedelijk Ziekenhuis Aalst
- Principal Investigator: G. Vandendriessche, MD, Jan Palfijnziekenhuis Ghent
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2008
Primary Completion (Actual)
May 27, 2009
Study Completion (Actual)
May 27, 2009
Study Registration Dates
First Submitted
March 14, 2008
First Submitted That Met QC Criteria
March 24, 2008
First Posted (Estimate)
March 25, 2008
Study Record Updates
Last Update Posted (Actual)
January 4, 2023
Last Update Submitted That Met QC Criteria
January 3, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2007/573
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.